Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of "Moderate Buy" from Analysts
Tactile Systems Technology, Inc. (NASDAQ:TCMD) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $38.60. Despite missing EPS estimates, the company exceeded revenue expectations in its latest quarter. Insider selling was observed, but institutional ownership remains high, with several major funds increasing or establishing positions.
How this was made

The 30-second read
Why it matters
The analyst consensus and institutional interest indicate positive sentiment, but earnings miss and insider selling introduce some uncertainty.
Market read
The news is highly relevant for investors in the healthcare device sector and those holding or considering TCMD shares.
What to watch
Potential upcoming regulatory changes or sector-wide shifts that could impact performance are not discussed.
Background
Tactile Systems Technology, Inc. specializes in medical devices for vascular and lymphedema conditions. Recent earnings reports show mixed results, with revenue exceeding expectations but EPS missing estimates.
Ticker impact
High relevance due to analyst ratings and institutional activity.
Moderate upward movement within the next 1-3 months, approximately 10-15% increase.
Analyst consensus and institutional buying support positive outlook, but earnings miss and insider selling introduce some risk.
Market effects
Potential positive influence on the medical device and life sciences sectors due to company-specific developments.
Limited regional impact; primarily affects investors focused on US markets.
Minimal global market impact given company size and sector.
Counterpoint
The earnings miss and insider selling could signal underlying issues, suggesting caution against aggressive buying.
Key entities
- CompanyTactile Systems Technology, Inc.
A medical device company focusing on vascular and lymphedema treatment devices.


